Chondroitinase ABC enhances pericontusion axonal sprouting but does not confer robust improvements in behavioral recovery.
Traumatic brain injury (TBI) results in enduring functional deficits. Strategies aimed at promoting plasticity within the injured brain may aid in enhancing functional outcome. We have previously shown that spontaneous pericontusional axon sprouting occurs within 7-14 days after controlled cortical impact injury in the adult rat, but ultimately fails due to an increasingly growth-inhibitory environment. We therefore sought to determine whether acute infusion of chondroitinase ABC into the site of the cortical contusion, to further reduce pericontusional growth-inhibitory chondroitin sulfate proteoglycans (CSPGs), would enhance and prolong the sprouting response. We also wanted to determine if chondroitinase-enhanced sprouting would ameliorate the behavioral deficits in forelimb function that occur in this model. Acute chondroitinase infusion decreased intact CSPGs and significantly increased pericontusional cortical grey and white matter growth-associated protein 43 (GAP43)-positive axon sprouting at 7 days post-injury. A return of intact CSPGs at later time points likely contributed to the absence of persistently increased levels of axon sprouting by 14-21 days post-injury. There was no overall benefit on forelimb function during the time of maximal sprouting or at any subsequent times in three of four behavioral outcome measures. However, there was a chondroitinase-induced improvement in recovery from unskilled limb use deficits on the staircase forelimb reaching test toward sham-injured values at 28 days, which was not achieved by the vehicle-treated rats, indicating that there is some minor functional benefit of the increased sprouting induced by chondroitinase treatment. The current results, together with data from spinal cord injury models after chondroitinase intervention, suggest that a combinatorial approach with the addition of neurotrophins and rehabilitation would result in more robust axon sprouting and consequently improve behavioral outcome.
Harris
Neil G
NG
The University of California-Los Angeles (UCLA) Brain Injury Research Center, Los Angeles, California 90095-7039, USA. ngharris@mednet.ucla.edu
Mironova
Yevgeniya A
YA
Hovda
David A
DA
Sutton
Richard L
RL
D000818:Animals; D001284:Atrophy; D001369:Axons / Q000187:drug effects*; D001522:Behavior, Animal / Q000502:physiology*; D001930:Brain Injuries / Q000188:drug therapy* / Q000473:pathology* / Q000523:psychology; D002452:Cell Count; D019765:Chondroitin ABC Lyase / Q000494:pharmacology*; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism; D019922:GAP-43 Protein / Q000378:metabolism; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D008297:Male; D009044:Motor Cortex / Q000293:injuries / Q000473:pathology; D019635:Neurosurgical Procedures; D011597:Psychomotor Performance / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013003:Somatosensory Cortex / Q000293:injuries / Q000473:pathology; D016138:Walking / Q000502:physiology
D011508:Chondroitin Sulfate Proteoglycans; D019922:GAP-43 Protein; D019765:Chondroitin ABC Lyase
Exp Brain Res. 1998 Aug;121(3):300-10
9746136
FASEB J. 2006 Mar;20(3):491-3
16407455
J Neurosci. 2005 Aug 3;25(31):7150-8
16079397
Exp Neurol. 2003 Jul;182(1):160-8
12821386
Science. 2002 Nov 8;298(5596):1248-51
12424383
J Neurosci. 2006 Apr 19;26(16):4406-14
16624960
J Neurotrauma. 2009 Dec;26(12):2323-33
19659409
J Cereb Blood Flow Metab. 2003 Feb;23(2):154-65
12571447
Acta Neuropathol. 1997 Oct;94(4):329-37
9341933
Nat Neurosci. 2001 May;4(5):465-6
11319553
Brain. 2007 Apr;130(Pt 4):915-25
17293357
J Neurochem. 2008 Jan;104(2):400-8
18005340
J Comp Neurol. 2000 Aug 28;424(3):521-31
10906717
J Neurosci. 2006 Jul 12;26(28):7405-15
16837588
J Neuropathol Exp Neurol. 2010 Feb;69(2):139-54
20084019
J Neurosci Res. 2003 Feb 1;71(3):427-44
12526031
J Neurosci Res. 2009 Oct;87(13):2937-50
19437549
Exp Neurol. 2003 Jul;182(1):87-102
12821379
Nat Neurosci. 2009 Sep;12(9):1145-51
19668200
J Neurosci Res. 2005 Sep 15;81(6):837-45
16041802
Exp Neurol. 2005 Nov;196(1):126-37
16109409
J Cereb Blood Flow Metab. 2005 Oct;25(10):1366-75
15889044
Brain. 2010 Aug;133(Pt 8):2331-47
20566484
J Neurosci. 2002 Mar 15;22(6):2225-36
11896162
J Neurosci. 2004 Jul 7;24(27):6209-17
15240813
J Neurosci Methods. 1991 Feb;36(2-3):219-28
2062117
Neurosci Lett. 1998 Oct 16;255(2):83-6
9835220
J Neurotrauma. 2002 May;19(5):587-99
12042094
Eur J Neurosci. 2005 Dec;22(12):3036-46
16367770
J Neurosci. 2003 Aug 6;23(18):7034-44
12904464
J Neurosci. 2010 Feb 3;30(5):1657-76
20130176
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3340-5
19884507
Nature. 2002 Apr 11;416(6881):636-40
11948352
J Neurosci. 2007 Feb 28;27(9):2176-85
17329414